Tarigan, Setia Putra
Division Of Thoracic Oncology, Department Of Pulmonology And Respiratory Medicine, Faculty Of Medicine, Universitas Sumatera Utara/Haji Adam Malik General Hospital, Medan, Indonesia.

Published : 17 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 17 Documents
Search

The Characteristics of The General Population in Medan Undergoing Lung Cancer Screening with NARU Febiyanti, Mica; Tarigan, Setia Putra; Soeroso, Noni Novisari; Eyanoer, Putri Chairani
Journal of Society Medicine Vol. 3 No. 10 (2024): Oktober
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i10.165

Abstract

Introduction: Indonesia introduced the NARU lung cancer screening form to assess individual risk levels for lung cancer, classifying them as low, medium, or high risk. This study aimed to analyze the characteristics of low, medium and high risk groups in Medan city. Methods: A quantitative, descriptive cross-sectional design was used, involving 100 individuals from primary health care facilities across 11 areas, who were evaluated using the 9-question NARU form. Evaluation concluded the individuals into low, medium, and high risk of lung cancer. Results: The  majority of the responded high-risk group for lung cancer, the majority were males aged 45-65 years. They had no personal or family history of cancer but were active smokers, worked in carcinogenic environments, and did not live in homes or environments with carcinogenic risks. Additionally, they had a history of COPD and/or TB. In the moderate-risk group, both males and females aged 45-65 years were included, with no personal or family cancer history. They were passive smokers, did not work in carcinogenic environments, and did not live in homes or environments with carcinogenic risks. None had a history of COPD or TB. In the low-risk group, the majority were females under 45 years. They had no personal or family cancer history, were non-smokers, did not work in carcinogenic environments, and did not live in homes or environments with carcinogenic risks. They also had no history of COPD or TB. Conclusion: The study concluded that in Medan, 48% of the population fell into the moderate-risk group for lung cancer, while 31% were in the low-risk group, and 21% were classified as high risk.
Thoracic CT Scan Image in Transudate and Exudate Pleural Effusion Cases at Haji Adam Malik General Hospital Medan in January - September 2024 Lokman, Yovita Belva; Putra, Dedy Dwi; Tarigan, Setia Putra; Malisie, Ririe Fachrina
Journal of Society Medicine Vol. 3 No. 12 (2024): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v3i12.185

Abstract

Introduction: Pleural effusion is the most common pleural disease, typically diagnosed through thoracentesis. However, thoracentesis carries risks of complications. Chest CT scans offer a non-invasive alternative to assess pleural effusion and distinguish between exudate and transudate types. Methods: This retrospective cross-sectional study was conducted on patients with pleural effusion at Haji Adam Malik General Hospital, Medan. A total of 80 patients were included. Statistical analysis was performed to evaluate the correlation between demographic, clinical, and thoracic CT findings with the type of pleural effusion. The Mann-Whitney test determined the efficacy of attenuation values in differentiating exudate and transudate. Results: Of the 80 patients, 57 (71.3%) had exudative pleural effusion and 23 (28.7%) transudative. The sample comprised 43 males (53.8%) and 37 females (46.3%), with a mean age of 48.44 ± 18.532 years (range: 2–84 years). Significant correlations were found between the etiology of pleural effusion and pleural nodules with effusion type (p = 0.000 and p = 0.023, respectively). No significant correlations were observed between age, gender, or other CT findings with effusion type (p > 0.05). Attenuation values on CT scans effectively distinguished exudative from transudative effusion (p = 0.000). A cutoff attenuation value of 17.5 Hounsfield Units (HU) demonstrated an AUC of 0.887, with 84.2% sensitivity and 82.6% specificity. Conclusions: Thoracic CT scans are effective for differentiating exudative and transudative pleural effusion. Significant differences were identified in etiology, pleural nodules, and attenuation values, supporting the use of CT imaging as a non-invasive diagnostic method
Effectiveness of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) on Life Expectancy in Non-Small Cell Lung Cancer Patients in Medan City Harahap, Putri Wulandari; Tarigan, Setia Putra; Soeroso, Noni Novisari; Ashar, Taufik
Journal of Society Medicine Vol. 4 No. 2 (2025): February
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i2.193

Abstract

Introduction: Non-small cell lung cancer (NSCLC) is strongly linked to epidermal growth factor receptor (EGFR) mutations, with tyrosine kinase inhibitors (TKIs) serving as a primary treatment. While TKIs demonstrate substantial antitumor effects, resistance differs across generations. This study evaluates the impact of first- and second-generation EGFR TKIs on the survival outcomes of NSCLC patients in Medan. Method: A retrospective cross-sectional study was conducted on 67 EGFR-positive NSCLC patients treated with TKIs between 2017 and 2022. Medical records from four hospitals-Haji Adam Malik Hospital, Elisabeth Hospital, Prof. Dr. Chairuddin Panusunan Lubis USU Hospital, and Pirngadi Hospital-were analyzed. Patients aged >18 years with EGFR mutations (exon 18, 19, or 21) and complete records were included. Survival outcomes, including Progression-Free Survival (PFS), Median Survival Time (MST), and Overall Survival (OS), were compared using the Mann-Whitney test. Results: All 67 patients received either first- or second-generation TKIs. Statistical analysis revealed that patients treated with second-generation TKIs had significantly better PFS, MST, and OS than those receiving first-generation TKIs (p < 0.05). Conclusion: This retrospective study faced limitations due to incomplete data and did not assess adverse effects. However, findings indicate that second-generation EGFR TKIs provide superior survival benefits for NSCLC patients compared to first-generation TKIs. Further prospective studies are needed to validate these results and explore the impact of treatment-related toxicity.
Characteristic of Adenocarcinoma Lung Patients With Ros-1 Mutation Among North Sumatra Population Ritonga, Adewita; Soeroso, Noni Novisari; Tarigan, Setia Putra
AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh Averrous, Volume 11 No.1 Mei 2025
Publisher : Fakultas Kedokteran Universitas Malikussaleh

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Lung cancer is expected to be the most frequent cancer by 2020, accounting for over 2 million diagnoses and approximately 1.8 million deaths globally. Lung cancer, the most prevalent cancer, is identified by histopathological characteristics such as ROS-1 mutations, which impact 0.9% to 2.6% of adenocarcinomas worldwide with no data from Indonesia. The aim of this study is to examine the clinical characteristics of patients with ROS-1-mutant adenocarcinomas. A study with a cross-sectional design. Clinical characteristics of patients include their gender, history of smoking, family history of cancer, clinical stage, and the histological grading of their adenocarcinoma in hospitals. ROS-1 using RT-PCR in conjunction with paraffin blocks. A total of 90 adenocarcinoma patients were included in the study. The majority of patients were male (66.7%), aged 41–60 years (55.6%), former smokers (67.8%), and had no family history of cancer (97.8%). The highest malignancy level was at stage IVA (82.2%), with poorly differentiated histopathological grading being the most common (53.3%). The detection of ROS-1 fusion in 2% of patients emphasizes the need for molecular analysis in assessing individual genetic risk. ROS-1 fusion detection was obtained in 2% of female patients who were younger (average age 50 years) and never smoked. Only 2% of patients in the North Sumatra region met the criteria for ROS-1 fusion, including being female, being younger than the average patient age of 50, and not smoking.
Correlation Between Fagerstrom Score and Brinkman Index With Spirometry Results in Lung Cancer Patients at Haji Adam Malik General Hospital and Prof. Dr. Chairuddin Panusunan Lubis Hospital University of North Sumatera Medan Agung Haganta Pinem; Setia Putra Tarigan; Amira P. Tarigan; Taufik Ashar
Jurnal Impresi Indonesia Vol. 4 No. 8 (2025): Jurnal Impresi Indonesia
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/jii.v4i8.6944

Abstract

Lung cancer is one of the leading causes of cancer-related deaths globally. Cigarette smoking remains the primary risk factor. The Fagerstrom Test for Nicotine Dependence (FTND) and the Brinkman Index are used to assess nicotine addiction and smoking intensity, respectively. These indices are associated with pulmonary function, typically assessed through spirometry. Objective: To determine the relationship between Fagerstrom scores and Brinkman Index with spirometry results in lung cancer patients. Methods: This quantitative observational study applied a cross-sectional design involving 68 smoking lung cancer patients at RSUP Haji Adam Malik and RS Prof. CPL Universitas Sumatera Utara. Data were collected via FTND and Brinkman Index questionnaires and spirometry testing. Data were analyzed using the Kruskal-Wallis test with a significance level of p<0.05. Results: Most patients exhibited moderate nicotine dependence (44.1%) and moderate smoking history per Brinkman Index (52.9%). Spirometry results indicated a high prevalence of obstructive and restrictive impairments. There was a significant correlation between FTND/Brinkman Index and lung function (p<0.001). Conclusion: Both Fagerstrom scores and Brinkman Index show a strong relationship with spirometry outcomes, indicating impaired pulmonary function among lung cancer patients.
Penilaian Cyfra 21-1 dan Cd8 pada NSCLC: Implikasi untuk Kemoterapi dan Prognosis di Medan Muhammad Faiz Tanjung; Noni Novisari Soeroso; Setia Putra Tarigan
Public Health and Safety International Journal Vol. 5 No. 01 (2025): Public Health and Safety International Journal (PHASIJ)
Publisher : YCMM

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55642/phasij.v5i01.987

Abstract

Kanker paru, khususnya Kanker Paru Non-Small Cell (NSCLC), merupakan penyebab utama kematian akibat kanker di seluruh dunia. NSCLC stadium lanjut sering kali diobati dengan kemoterapi, sehingga pemahaman tentang biomarker sangat penting untuk prognosis dan respons pengobatan. Biomarker seperti CYFRA 21-1 dan CD8 sangat penting dalam menilai karakteristik tumor, respons imun, dan prognosis secara keseluruhan pada pasien NSCLC. Penelitian ini mengevaluasi implikasi klinis CYFRA 21-1 dan CD8 pada pasien NSCLC yang menjalani kemoterapi di Medan, Indonesia. Penelitian deskriptif observasional dilakukan terhadap 20 pasien NSCLC dari RSUP H. Adam Malik, RSUP Prof. Chairuddin P. Lubis, dan RS St. Dengan menggunakan total sampling, kadar CYFRA 21-1 dan CD8 dinilai. Analisis data dilakukan dengan menggunakan SPSS versi 26. Hasil: Penelitian ini menemukan bahwa semua peserta adalah laki-laki, dengan 55% berusia di atas 60 tahun. Adenokarsinoma adalah subtipe yang paling umum (60%), dan 70% pasien didiagnosis pada stadium IV A. Kadar CD8 menunjukkan rentang yang luas, yang menunjukkan respons imun yang bervariasi. Sebaliknya, tingkat CYFRA 21-1 menyoroti potensinya dalam memprediksi perkembangan penyakit. Studi ini menggarisbawahi pentingnya CYFRA 21-1 dan CD8 dalam menilai tingkat keparahan penyakit dan memandu strategi terapeutik, yang berpotensi meningkatkan hasil klinis dalam pengobatan NSCLC.
Platinum-Based Chemotherapy Regimens and the Incidence of Chemotherapy Toxicity in Patients with Lung Cancer in Medan, Indonesia Faidul Hidayati Siska Ginting; Noni Novisari Soeroso; Setia Putra Tarigan; Putri Chairani Eyanoer; David Chi Leung Lam
Jurnal Respirasi Vol. 12 No. 3 (2026): September 2026
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jr.v12-I.3.2026.250-257

Abstract

Introduction: Platinum-based chemotherapy remains the standard first-line therapy for advanced lung cancer; however, its administration is frequently associated with various hematologic and non-hematologic toxicities that may affect patient outcomes and quality of life. Understanding the toxicity profile of platinum-based regimens is essential for optimizing supportive care and treatment monitoring. Objective: This study aimed to analyze the association between platinum-based chemotherapy regimens and the incidence of chemotherapy-related toxicities in lung cancer patients in Medan. Methods: A retrospective study was conducted using medical records of lung cancer patients treated at Prof. dr. Chairuddin P. Lubis Universitas Sumatera Utara Hospital and Adam Malik Hospital from January 2023 to June 2025. Sequential sampling was applied to patients who had received at least two cycles of platinum-based chemotherapy. Hematologic and non-hematologic toxicities were assessed and graded according to the highest toxicity level observed during treatment. Data were analyzed using univariate analysis and Chi-square tests with SPSS version 29. Results: A total of 134 patients were included, predominantly male (85.07%) and aged over 60 years (48.51%). Adenocarcinoma was the most common subtype (57.46%), while carboplatin-based regimens were more frequently administered (75.37%). The most common hematologic toxicity was anemia (76.12%), whereas myalgia (95.52%), pulmonary complications (87.31%), nausea/vomiting (85.82%), and alopecia (75.37%) were the most frequent non-hematologic toxicities. Significant associations were identified between platinum-based chemotherapy regimens and the occurrence of diarrhea (p=0.011) and oral mucositis (p=0.008). Conclusion: Platinum-based chemotherapy in lung cancer patients is associated with substantial hematologic and non-hematologic toxicities, particularly myalgia and pulmonary complications. Carboplatin regimens were more commonly used and generally showed a milder toxicity profile compared with cisplatin. Early monitoring and regimen-specific supportive management are recommended to reduce chemotherapy-related complications.